X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Torrent Pharma Fact Sheet, Torrent Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Torrent Pharma Fact Sheet   (TORR)

Here is the latest financial fact sheet of Torrent Pharma. For more details, see the Torrent Pharma quarterly results and Torrent Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

TORRENT PHARMA Price History

Price Rs 1,660.7
Mkt Cap Rs m 281,082
Vol '000 4.4
P/E X 44.8
P/CF X 25.9
EPS (TTM) Rs 37.1
% ch % -0.7
No. of shares m 169.26
% ch week % 0.9
% ch 1-mth % 2.3
% ch 12-mth % 30.8
52 week H/L Rs 1,872.0/1,223.8
(As on Nov 16, 2018 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

TORRENT PHARMA Financials

No. of Mths
Year Ending
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
5-Yr Chart
Click to enlarge
TORRENT PHARMA EQUITY SHARE DATA
High Rs5781,2321,7201,7681,550 
Low Rs3345231,1341,1861,144 
Sales per share (Unadj.) Rs247.3275.0394.5346.1354.7 
Earnings per share (Unadj.) Rs39.244.4102.455.240.1 
Diluted earnings per shareRs39.244.4102.455.240.1 
Cash flow per share (Unadj.) Rs44.455.6116.573.364.2 
Dividends per share (Unadj.) Rs10.0011.2540.0014.0014.00 
Adj. dividends per shareRs10.0011.2539.9914.0014.00 
Dividend yield (eoy) %2.21.32.80.91.0 
Book value per share (Unadj.) Rs112.4156.2206.5257.1273.1 
Adj. book value per shareRs112.4156.1206.4257.0273.1 
Shares outstanding (eoy) m169.22169.22169.22169.22169.22 
Bonus/Rights/Conversions  B1:1---- 
Price / Sales ratio x1.83.23.64.33.8 
Avg P/E ratio x11.619.813.926.833.6 
P/CF ratio (eoy) x10.315.812.320.121.0 
Price / Book Value ratio x4.15.66.95.74.9 
Dividend payout %25.525.439.125.434.9 
Avg Mkt Cap Rs m77,190148,465241,435249,887227,897 
No. of employees `0009.511.010.911.814.7 
Total wages/salary Rs m7,4118,4188,4249,93411,353 
Avg. sales/employee Rs Th4,386.54,212.46,129.64,971.54,083.0 
Avg. wages/employee Rs Th776.8762.0773.4843.2772.3 
Avg. net profit/employee Rs Th695.9679.81,591.3792.4461.3 
TORRENT PHARMA INCOME DATA
Net Sales Rs m41,84746,53566,76458,56960,021 
Other income Rs m3812,8562,2562,2332,988 
Total revenues Rs m42,22949,39069,02060,80263,009 
Gross profit Rs m9,51510,20227,33013,77313,493 
Depreciation Rs m8701,9072,3763,0694,086 
Interest Rs m5861,7521,8402,0563,085 
Profit before tax Rs m8,4409,39825,37110,8819,310 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00-1,93600 
Tax Rs m1,8011,8886,1021,5452,529 
Profit after tax Rs m6,6397,50917,3339,3366,781 
Gross profit margin %22.721.940.923.522.5 
Effective tax rate %21.320.124.114.227.2 
Net profit margin %15.916.126.015.911.3 
TORRENT PHARMA BALANCE SHEET DATA
Current assets Rs m34,04540,98346,88248,79452,623 
Current liabilities Rs m21,74627,04632,85527,38352,022 
Net working cap to sales %29.430.021.036.61.0 
Current ratio x1.61.51.41.81.0 
Inventory Days Days88847497120 
Debtors Days Days96125795976 
Net fixed assets Rs m14,09534,72039,00742,07985,016 
Share capital Rs m846846846846846 
"Free" reserves Rs m17,27225,58334,09542,65545,376 
Net worth Rs m19,02426,43034,94143,50146,222 
Long term debt Rs m7,44521,72918,50122,40841,115 
Total assets Rs m50,69879,64190,57997,021142,432 
Interest coverage x15.46.414.86.34.0 
Debt to equity ratio x0.40.80.50.50.9 
Sales to assets ratio x0.80.60.70.60.4 
Return on assets %14.311.621.211.76.9 
Return on equity %34.928.449.621.514.7 
Return on capital %34.123.247.319.614.2 
Exports to sales %37.430.443.300 
Imports to sales %8.26.06.900 
Exports (fob) Rs m15,66514,13628,93400 
Imports (cif) Rs m3,4162,8014,58400 
Fx inflow Rs m16,86214,26529,18520,06614,580 
Fx outflow Rs m5,1965,1846,0215,3043,600 
Net fx Rs m11,6669,08123,16514,76210,980 
TORRENT PHARMA CASH FLOW
From Operations Rs m 5,994 8,102 27,421 10,088 8,942 
From Investments Rs m -3,558 -21,623 -8,379 -7,869 -47,070 
From Financial Activity Rs m 864 12,123 -14,352 -1,929 34,174 
Net Cashflow Rs m 3,300 -1,399 4,375 177 -3,655 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 71.5%
Foreign collaborators 0.0%
Indian inst/Mut Fund 7.0%
FIIs 12.6%
ADR/GDR 0.0%
Free float 8.8%
Shareholders 26,511
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Torrent House, Off Ashram Road, Ahmedabad - 380 009
E-MAIL maheshagrawal@torrentpharma.com WEB www.torrentpharma.com
TELEPHONE (079) 2658 5090 FAX (079) 2658 2100
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR Deloitte Haskins & Sells
CHM: Sudhir Mehta COMP SEC: Mahesh Agarwal YEAR OF INC: 1973 BSE CODE: 500420 FV (Rs): 5 DIV YIELD (%): 0.8

More Pharmaceuticals Company Fact Sheets:   AMAR REMEDIES  ALEMBIC LTD  STRIDES PHARMA SCIENCE  DISHMAN PHARMA  AJANTA PHARMA  

Compare TORRENT PHARMA With:   AMAR REMEDIES  ALEMBIC LTD  STRIDES PHARMA SCIENCE  DISHMAN PHARMA  AJANTA PHARMA  

Compare TORRENT PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Macroeconomic Cues Guide the Markets This Week(Podcast)

Global markets remained in pressure this week. Pound fell sharply as risk of chaotic Brexit rose.

Views on news

TORRENT PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 12.3% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 12.3% YoY). Sales on the other hand came in at Rs 19 bn (up 32.5% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY19); Net Profit Down 13.3% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 13.3% YoY). Sales on the other hand came in at Rs 19 bn (up 36.2% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

Does it Make Sense to Invest in Offshore Funds?(Outside View)

Nov 6, 2018

Many investors prefer to invest in offshore funds because of the rupee depreciation and on-going downtrend in the markets, but it is to be invested only when there is no option available to invest in India.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA - ADCOCK INGRAM COMPARISON

COMPARE TORRENT PHARMA WITH

MARKET STATS